6th February 2018
In accordance with the AIBA Anti-Doping Rules, AIBA has reached a settlement agreement on the case Muhammad ALI (ENG) 2017-IC-02 with the other party, the English boxer, Muhammad Ali, who has received a 2-year suspension for testing positive for a substance included on the WADA Prohibited List.
The boxer tested positive for type S1. 1A Exogenous AAS substances at the in-competition test conducted on the occasion of the World Series of Boxing match between Morocco Atlas Lions vs British Lionhearts held on April 21st, 2017. In accordance with the AIBA Anti-Doping Rules and the World Anti–Doping Code, the Boxer and England Boxing have been notified about the findings.
The International Boxing Association (AIBA) welcomes and fully supports the anti-doping testing procedure put in place for competitions. AIBA is working with WADA to ensure that boxing is doping free and will take the appropriate action regarding this case.